Sort by
Refine Your Search
-
Listed
-
Employer
- University of Oxford
- KINGS COLLEGE LONDON
- King's College London
- AALTO UNIVERSITY
- University of Oxford;
- The University of Edinburgh;
- University of Liverpool
- University of London
- ;
- Atlantic Technological University;
- City University London
- Heriot Watt University
- Imperial College London;
- King's College London;
- Nature Careers
- UNIVERSITY OF VIENNA
- University of Cambridge
- University of Cambridge;
- University of Dundee;
- University of Liverpool;
- 10 more »
- « less
-
Field
-
their target antigens and become activated in serious human diseases, including autoimmune disorders, infectious diseases, and cancers. We study how adaptive T cell immunity is developed and/or becomes impaired
-
plans (and ongoing review) to ensure that targets are met according to study timelines. Supervision would be provided by senior Centre staff, including Professor Cathy Creswell. About You You will have or
-
mechanisms that can lead to the development of novel therapeutic targets. The individual will report to the PI of the headache Group, Dr Philip R Holland and will be responsible for conducting their own
-
world-leading researchers from Oxford, Harvard, and other premier institutions to develop innovative gene-silencing and gene-editing technologies targeting the underlying causes of genetic heart diseases
-
into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. You will hold a relevant PhD/DPhil, together with sufficient specialist knowledge in normal and malignant
-
gene-silencing and gene-editing technologies targeting the underlying causes of genetic heart diseases. The successful candidate will work closely with chemists, molecular biologists, and clinicians
-
to the development and implementation of strategies/action plans (and ongoing review) to ensure that targets are met according to study timelines. Supervision would be provided by senior Centre staff, including
-
well as localization of targets or signal sources in passive-sensing settings. This is central to future 6G wireless communications applications, where radio-frequency sensing and data transfer (ISAC) are integrated
-
to investigate host-pathogen interactions for identification of novel targets for drug discovery. The main objective of this post is to conduct research on human pathogens using microbiology and molecular biology
-
primary headache disorders and related co-morbid conditions to help uncover novel disease mechanisms that can lead to the development of novel therapeutic targets. The individual will report to the PI